Genmab executive team joins fireside chats at upcoming investor healthcare conferences
PUBT·- Genmab executives are scheduled to participate in fireside chats at multiple investor healthcare conferences in September 2026. - The events include the Wells Fargo conference in Boston on Sept. 9, the Morgan Stanley conference in New York on Sept. 15, and the Bank of America conference in London on Sept. 22. - These engagements provide corporate updates and informational insights for investors within the healthcare sector.Genmab: Buy Rating Backed by Pivotal Epkinly Data Conviction and Blockbuster Potential Across Key Oncology Programs
Tip Ranks·- William Blair analyst Matt Phipps reaffirmed a buy rating on Genmab stock on August 7. - The rating is supported by strong confidence in upcoming key clinical data for oncology programs including Epkinly, petosemtamab, and Rina-S. - Management maintains strong confidence in the EPCORE DLBCL-2 study, anticipating significant clinical benefits and commercial opportunities.